Receiving appropriate antibiotic therapy in a timely manner is important, but clinicians must also consider potential antibiotic resistance in the hospital and surrounding community.
Approaches to emergency department community-acquired pneumonia care can incorporate either guideline-based serial clinical assessment or procalcitonin-driven strategies.
A combination dose of ceftolozane/tazobactam is noninferior to meropenem for treating nosocomial pneumonia.
Using serum biomarkers along with clinical signs and symptoms may be useful for differentiating definite bacterial from other pneumonias in a highly vaccinated population.
The risk of pneumonia is highest within first month of antiepileptic drug use but persists through 2 years.
The presence of low serum albumin and crazy paving ground glass opacities on high-resolution computed tomography at the time of non-HIV Pneumocystis jirovecii pneumonia diagnosis were predictive of poor prognosis.
Recommending pneumococcal vaccination for all 50-year-olds prevents the most disease in underserved minorities and the general population.
Lack of plumbing maintenance; aging infrastructure; warm, humid climates; and exposure to the immunocompromised may contribute to an increase in Legionnaires disease.
A novel antibiotic, lefamulin, may not be inferior to moxifloxacin in efficacy and safety for the treatment of community-acquired bacterial pneumonia.
Use of rapid polymerase chain reaction-based diagnostic tests for MRSA significantly reduced the use of vancomycin and linezolid in patients who were mechanically ventilated with suspected pneumonia at risk for MRSA.
